Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
252.15
0.00 (0.00%)
Jul 3, 2025, 4:00 PM EDT - Market closed
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Life Science | 1.03B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Life Science Growth | -7.43% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Clinical Diagnostics | 1.54B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Clinical Diagnostics Growth | 1.34% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Segments | 500.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Segments Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2011 - 2018 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2011 - 2018 |
Other |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Life Science Operating Profit |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Life Science Operating Profit Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Clinical Diagnostics Operating Profit |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Clinical Diagnostics Operating Profit Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Segments Operating Profit |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Segments Operating Profit Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Gross Income by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 820.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 820.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Life Science Segment Profit | 582.40M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Life Science Segment Profit Growth | -2.51% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Clinical Diagnostics Segment Profit | 796.60M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Clinical Diagnostics Segment Profit Growth | -8.59% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Segments Segment Profit | -100.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Segments Segment Profit Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 820.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
United States | 1.04B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States Growth | -4.41% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EMEA | 834.10M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EMEA Growth | 2.27% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
APAC | 521.60M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
APAC Growth | -6.59% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Regional | 169.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Regional Growth | 0.48% |
Log In |
Log In |
Log In |
Log In | Upgrade
|